
    
      This study will evaluate the safety and determine the maximal tolerated dose of anti-OX40;
      evaluated the immune response to the study treatment; measure the pharmacokinetics of
      anti-OX40; monitor tumor regression, and identify the most biologically active dose of
      anti-OX40 to induce antigen-specific responses to a variety of immunogens.
    
  